🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

11,276 results for “Te” Clear

  1. berberine hydrochloride

    The First People's Hospital of Lianyungang

    Hypertension

    approved small molecule active

    1 trial

  2. bimekizumab

    Lacuna Pharma Pty Ltd

    Moderate to Severe Plaque Psoriasis, Psoriatic arthritis

    approved small molecule active

    1 trial

  3. biphasic insulin aspart 30

    Novo Nordisk A/S

    Diabetes

    approved small molecule completed

    2 trials

  4. budesonide/formoterol

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Cough Variant Asthma

    approved small molecule active

    1 trial

  5. buprenorphine

    Indivior Pty Ltd

    Opiate-related Disorders

    approved small molecule completed

    1 trial

  6. butylphthalide(NBP)

    The First People's Hospital of Lianyungang

    Acute Ischemic Stroke

    approved small molecule completed

    1 trial

  7. cagrilintide, Placebo + Placebo, semaglutide, cagrilintide, cagrilintide semaglutide, semaglutide, semaglutide, semaglutide, cagrilintide semaglutide, semaglutide, cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide semaglutide, cagrilintide, cagrilintide

    NovoThirteen

    Obesity and T2D

    approved small molecule active

    1 trial

  8. combined fixed dose combination

    United Therapeutics Europe Ltd

    Tuberculosis

    approved small molecule active

    1 trial

  9. counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Amphetamine-Related Disorders

    approved other active

    1 trial

  10. counseling

    BRIGHT MINDS BIOSCIENCES INC.

    Substance-Related Disorders

    approved other completed

    1 trial

  11. crizotinib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Systemic Anaplastic Large-Cell Lymphoma

    approved small molecule terminated

    1 trial

  12. diclofenac sodium topical gel

    Teva Pharma GmbH

    Multiple Sclerosis

    approved small molecule completed

    1 trial

  13. dipyridamole

    United Therapeutics Europe Ltd

    Coronary Artery Disease

    approved small molecule terminated

    1 trial

  14. doxazosin plus tolterodine SR

    Samsung Bioepis NL B.V.

    Overactive Bladder

    approved small molecule completed

    1 trial

  15. dupilumab

    Regeneron UK Limited

    Chronic Obstructive Pulmonary Disease (COPD)

    approved small molecule active

    1 trial

  16. dupilumab

    Regeneron UK Limited

    Severe Atopic Dermatitis (AD)

    approved small molecule terminated

    1 trial

  17. early enteral nutrition

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Acute Pancreatitis

    approved small molecule completed

    1 trial

  18. entecavir

    The First People's Hospital of Lianyungang

    Liver Fibrosis

    approved small molecule completed

    1 trial

  19. epoprostenol

    Ultragenyx UK Limited

    Hypertension, Pulmonary

    approved small molecule completed

    1 trial

  20. fluocinolone acetonide 190 micrograms

    ANI PHARMACEUTICALS INC

    Non-infectious Uveitis Affecting the Posterior Segment of the Eye

    approved small molecule active

    1 trial

  21. fluticasone/salmeterol, tiotropium

    Hospital Authority, Hong Kong

    COPD

    approved small molecule active

    1 trial

  22. formoterol fumarate

    Universal Integrated

    Pulmonary Disease, Chronic Obstructive

    approved small molecule completed

    1 trial

  23. ginkgolide

    The First People's Hospital of Lianyungang

    Intravenous Alteplase Thrombolysis

    approved small molecule completed

    1 trial

  24. glargine + exenatide

    Hong Kong Baptist University

    Type 2 Diabetes Mellitus

    approved small molecule completed

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources